Disse tilfælde er ofte forbundet med andre antiretrovirale midler og vil muligvis forventes at opstå, når VIRAMUNE anvendes i kombination med disse midler.
These events are commonly associated with other antiretroviral agents and may be expected to occur when VIRAMUNE is used in combination with other agents; however it is unlikely that these events are due to VIRAMUNE treatment.